Uni-Bio Science Group Limited (HKG:0690)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.0760
-0.0040 (-5.00%)
Jul 31, 2026, 4:08 PM HKT

Uni-Bio Science Group Cash Flow Statement

Millions HKD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
93.3382.7770.8838.51-19.59
Depreciation & Amortization
17.5217.3516.4417.0920.37
Other Amortization
3.994.010.440.460.48
Loss (Gain) From Sale of Assets
0.080.570.610.762.63
Asset Writedown & Restructuring Costs
-----0
Loss (Gain) From Sale of Investments
-0.35-0.13---0.04
Stock-Based Compensation
1.010.18-0.543.93
Provision & Write-off of Bad Debts
1.225.481.12.27-1.94
Other Operating Activities
-0.39.970.30.3312.19
Change in Accounts Receivable
-22.95-27.01-1.070.8214.46
Change in Inventory
-3.69-3.29-4.392.08-23.19
Change in Accounts Payable
-2.94-16.3911.52-13.91-4.28
Change in Unearned Revenue
1.88-6.83.02-0.37.03
Operating Cash Flow
88.7966.7198.8548.6612.04
Operating Cash Flow Growth
33.10%-32.52%103.14%304.09%-

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-52.23-38-59.74-28.43-8.43
Sale of Property, Plant & Equipment
0.240.14-0.10.02
Investment in Securities
--114.75--36.36
Other Investing Activities
120.27-15.46-16.411.314.18
Investing Cash Flow
68.28-168.07-76.14-27.0342.12

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
4.775.137.2115.247.64
Long-Term Debt Issued
41.8570.441.88--
Total Debt Issued
46.6375.5449.0915.247.64
Short-Term Debt Repaid
-3.63-6.72-3.59--
Long-Term Debt Repaid
-59.13-15.01-15.04-3.83-0.68
Total Debt Repaid
-62.77-21.73-18.63-3.83-0.68
Net Debt Issued (Repaid)
-16.1453.8130.4611.416.97
Repurchase of Common Stock
--24.83-5.17--6.01
Other Financing Activities
-18.05-12.15-0.78-8.83-0.48
Financing Cash Flow
-34.1816.8324.512.580.48

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-8.289.51-16.2-9.63.96
Net Cash Flow
114.61-75.0331.0214.6158.6

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
36.5628.7139.1120.233.61
Free Cash Flow Growth
27.35%-26.59%93.33%460.70%-
Free Cash Flow Margin
6.24%5.19%8.07%4.59%1.02%
Free Cash Flow Per Share
0.010.010.010.000.00
Levered Free Cash Flow
19.78-14.2518.1725.834.81
Unlevered Free Cash Flow
20.72-13.518.6626.0435.11

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1.511.190.780.380.48
Cash Income Tax Paid
8.326.468.943.621.43
Change in Working Capital
-27.7-53.489.08-11.3-5.99